Shortcuts


Asha S. Collins, PhD

Senior Vice President, General Manager of Biobanks, DNAnexus, Inc.

Independent Director

Age: 48

Director since:
November 2020

Committees:
Finance
Governance and Corporate Responsibility

Experience

DNAnexus, Inc.

  • Senior Vice President, General Manager of Biobanks (since August 2021)


Genentech, Inc. (a subsidiary of Roche Holding A.G.)

  • Head of U.S. Clinical Operations (May 2018 – June 2021)


McKesson Corporation

  • Vice President of Clinical Sourcing and Business Development (November 2015 – March 2018)
  • Senior Director, Corporate Strategy and Business Development (September 2014 – November 2015)


Quintiles

  • Principal Consultant (2011 – 2014)


Deloitte Consulting

  • Manager (2008 – 2011)


Other Experience

  • Selected as a Health Innovators fellow by The Aspen Institute in July 2019

Qualifications

  • Science, Technology and R&D: Significant experience overseeing scientific innovation and research development efforts in the healthcare field, developed during her tenure as General Manager of Biobanks at DNAnexus, Inc., a cloud-based genome informatics and data management company that leverages a multiomics and multimodal cloud-based platform to fuel scientific discovery and innovation, and previously as the Head of U.S. Clinical Operations at Genentech, a biotechnology company.
  • Operations: Valuable experience managing complex business operations, gained as a result of leadership positions held at various life science and healthcare companies, including as Head of U.S. Clinical Operations for Genentech, Inc. and as General Manager of Biobanks at DNAnexus, Inc., where she established and continues to scale the global operations and commercialization of the data analysis business.
  • Corporate Strategy: Significant experience developing and implementing corporate strategy, including in her role as Senior Director, Corporate Strategy and Business Development at McKesson Corporation and as General Manager of Biobanks at DNAnexus, Inc.
  • Dr. Collins also brings significant corporate governance, executive leadership, digital, international business and risk oversight skills and experience to the Board.

Education

  • BS, Biology, University of Pittsburgh
  • PhD, Cancer Biology and Microbiology, University of Wisconsin-Madison